Keywords: China, Colorectal cancer drugs, Markt forecast, Decision Resources, Merck KGaA, Erbitux, Roche, Avastin

Chinese colorectal cancer drug market forecast to grow to over $400 million in 2016

Article | 04 April 2012

Print This

The colorectal cancer drug market in China will grow from a value of $261 million in 2011 to $404 million in 2016, according to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in